TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
林柏宏LIN, PO-HUNG
- 計畫主持人
- 執行臨床試驗年資 12 年 9 個月
-
m7587@cgmh.org.tw
發表文獻
28筆
21
Liu JM, Lin PH, Hsu RJ, Chang YH, Cheng KC, Pang ST, Lin SK*. Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer. Medicine (Baltimore). 2016 Aug;95(31):e4475.
22
Shao IH, Chang YH*, Yu KJ, Lin PH, Liu CY, Chuang CK, Pang ST. Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma. Kaohsiung J Med Sci. 2016 Apr;32(4):191-5.
23
Lu SH, Tsai WS, Chang YH, Chou TY, Pang ST, Lin PH, Tsai CM, Chang YC*. Identifying cancer origin using circulating tumor cells. Cancer Biol Ther. 2016 Apr 2;17(4):430-8.
24
Lin PH, Lin SK, Hsu RJ, Cheng KC, Liu JM*. The Use and the Prescription Pattern of Traditional Chinese Medicine Among Urolithiasis Patients in Taiwan: A Population-Based Study. The Journal of Alternative and Complementary Medicine 2015 Sep 11
25
Liu CY, Chuang CK, Chang YH, Chuang HC, Yu KJ, Lin PH, Pang ST*. Maintenance bacillus CalmetteeGuerin therapy prolongs recurrence-free survival in non-muscle-invasive bladder cancer: A real-world experience. Urol Scien. 26 (2015) 96-100.
26
Liu CY, Pang ST, Chang YH, Yu KJ, Lin PH, Chuang CK*. Paratesticular metastasis from colorectal adenocarcinoma. Urol Scien. 26 (2015) 72-74.
27
Lin KJ, Lin PH, Chu SH, Chen HW, Wang TM, Chiang YJ, Liu KL, Wang HH*. The impact of climate factors on the prevalence of urolithiasis in Northern Taiwan. Biomed J. 2014 Jan-Feb;37(1):24-30. doi: 10.4103/2319-4170.117888.
28
Lin PH, Wang TM*, Chiang YJ, Huang CT, Chen HW, Chu SH, Liu KL, Lin KJ. Differences in preputial-colonizing bacteria between balanoposthitis and physiological phimosis. Urological Science 2012; 23(4): 114-117.
